InsidersTradesSigma
Explore the full record of transactions filed by Bartram Richard, Chief Financial Officer. Insider active across 1 companies, notably Esperion Therapeutics, Inc.. In total, 3 reports have been recorded. The latest transaction was disclosed on 14 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Richard Bartram is the Chief Financial Officer at Esperion Therapeutics, Inc. He is responsible for managing the company's finances, including accounting, financial planning, and financial reporting.